New advancement in anthelmintic drugs in veterinary medicine.

Trends Parasitol

Novartis Animal Health, Centre de Recherche Santé Animale SA, 1566St Aubin, Switzerland.

Published: March 2013

Anthelmintic treatment of nematode infections remains the mainstay of worm control in farm and companion animals. However, control is threatened by the occurrence of drug resistant nematodes. In recent years, three new anthelmintics have been introduced to the market. Here, we describe the main features including mode of action, availability, spectrum, dose, tolerability, safety, and resistance of emodepside, monepantel, and derquantel.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pt.2013.01.001DOI Listing

Publication Analysis

Top Keywords

advancement anthelmintic
4
anthelmintic drugs
4
drugs veterinary
4
veterinary medicine
4
medicine anthelmintic
4
anthelmintic treatment
4
treatment nematode
4
nematode infections
4
infections remains
4
remains mainstay
4

Similar Publications

Anions play a crucial role in various environmental, chemical, and biological processes. Among various anions, the production of perchlorate (ClO ) ion is expected to rise in upcoming years, and thus, an efficient method for the detection of perchlorate ion is highly desirable. In this effort, a pyridyl-benzimidazole-based luminescent probe (RSB1) containing two N-H donor sites has been synthesized for selective detection of perchlorate ion.

View Article and Find Full Text PDF

First case report of isolated pleural cysticercosis demonstrating pleuroscopic findings.

Respir Med Case Rep

December 2024

Pulmonary and Critical Care Division, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.

Pulmonary cysticercosis is a rare manifestation of human cysticercosis, which mostly occurs in developing countries. The disease can affect the lung parenchyma and pleura, resulting in pulmonary nodules, pneumonitis, lung cavities, or pleural effusion. We herein present a case involving a man of advanced age who presented with symptomatic eosinophilic pleural effusion.

View Article and Find Full Text PDF

Avermectins and Their Derivatives: Recent Advances in Biosynthesis and Application.

J Agric Food Chem

January 2025

Key Laboratory of Bioorganic Synthesis of Zhejiang Province, College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310014, China.

Avermectins (AVMs) and their derivatives are the most effective and widely used nematicides, insecticides, and acaricides against endo- and ectoparasites of plants, animals, and humans. Demand for avermectins and their highly effective derivatives has increased due to their high cost-effectiveness and wide range of applications as medicines and crop protection products. Due to the unique structures of these compounds and for industrial production purposes, numerous efforts and strategies have been dedicated to enhancing the production of avermectins and creating new analogues in recent years.

View Article and Find Full Text PDF

For thousands of years, has been widely used as an herbal medicine to treat some diseases and symptoms, including respiratory, gastrointestinal and urogenital ailments. The present study was adapted to document and assemble existing information about and its evidence-based ethnopharmacological activities, with brief reviews on the description, geographical distribution, ecology, medical uses and phytochemistry. A literature review and information up to 2024 was performed in various scientific databases, including PubMed, Science Direct and Google Scholar.

View Article and Find Full Text PDF

Piperazine-based P2X4 receptor antagonists.

Arch Pharm (Weinheim)

January 2025

European Institute for Molecular Imaging (EIMI), University of Muenster, Muenster, Germany.

The P2X4 receptor (P2X4R), a ligand-gated ion channel activated by ATP, plays a critical role in neuroinflammation, chronic pain, and cancer progression, making it a promising therapeutic target. In this study, we explored the design and synthesis of piperazine-based P2X4R antagonists, building on the structural framework of paroxetine. A series of over 35 compounds were synthesized to investigate structure-activity relationships (SARs) in a Ca²⁺-flux assay for P2X4R antagonistic activity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!